Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder
Condition: Binge-Eating Disorder Interventions: Drug: ACT-539313; Drug: Placebo Sponsor: Idorsia Pharmaceuticals Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials